Dominique Lejeune

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 14

Top Topics

Venous Thromboembolism

Bariatric Surgery

Oral Anticoagulants

Top Venues

Journal of medical economics

The Journal of asthma : official journal of the Association for the Care of Asthma

Journal of thrombosis and thrombolysis

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States. Journal of thrombosis and thrombolysis 54 (3) (2022)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population. Journal of medical economics 24 (1) (2021)
Neal D Shore, Raluca Ionescu-Ittu, Lingfeng Yang, François Laliberté, Malena Mahendran, Dominique Lejeune, Louise Yu, Joseph Burgents, Mei Sheng Duh, Sameer R Ghate
Real-world genetic testing patterns in metastatic castration-resistant prostate cancer. Future oncology (London, England) 17 (22) (2021)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population. Current medical research and opinion 37 (6) (2021)
François Laliberté, Veronica Ashton, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Jeffrey S Berger
Economic burden of rivaroxaban and warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy. Journal of comparative effectiveness research 10 (16) (2021)
Xiaoqin Yang, François Laliberté, Guillaume Germain, Monika Raut, Mei Sheng Duh, Shuvayu S Sen, Dominique Lejeune, Kaushal Desai, Philippe Armand
Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States. Journal of medical economics 24 (1) (2021)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US). Advances in therapy 38 (7) (2021)
Alok A Khorana, Keith R McCrae, Dejan Milentijevic, François Laliberté, Dominique Lejeune, Concetta Crivera, Patrick Lefebvre
Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer. Journal of medical economics 23 (4) (2020)
Heather M Rozjabek, Craig I Coleman, Veronica Ashton, François Laliberté, Paul Oyefesobi, Dominique Lejeune, Guillaume Germain, Jeff R Schein, Zhong Yuan, Patrick Lefebvre, Eric D Peterson
Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants. Journal of medical economics 22 (8) (2019)
Michael Streiff, Dejan Milentijevic, Keith R McCrae, François Laliberté, Dominique Lejeune, Patrick Lefebvre, Jeff Schein, Alok A Khorana
Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants. Journal of medical economics 22 (11) (2019)
Alok A Khorana, Keith McCrae, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera, Patrick Lefebvre, Dominique Lejeune, Heather Rozjabek, Jeff Schein, Michael B Streiff
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation. American journal of hematology 94 (2) (2018)
Hector Ortega, Jean-Pierre Llanos, Marie-Helene Lafeuille, Mei Sheng Duh, Guillaume Germain, Dominique Lejeune, Susan Sama, Chris Bell, Beth Hahn
Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data. The Journal of asthma : official journal of the Association for the Care of Asthma 56 (8) (2018)
Philip Stephen Wells, Anthonie W A Lensing, Lloyd Haskell, Bennett Levitan, François Laliberté, Michael Durkin, Veronica Ashton, Yongling Xiao, Concetta Crivera, Dominique Lejeune, Jeff Schein, Patrick Lefebvre
Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results. Journal of medical economics 21 (6) (2018)
Jeffrey S Berger, Roger Seheult, François Laliberté, Concetta Crivera, Dominique Lejeune, Yongling Xiao, Jeff Schein, Patrick Lefebvre, Scott Kaatz
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism. Research and practice in thrombosis and haemostasis 2 (1) (2017)